Nhlrc2 Antibodies

AND Nhlrc2 ELISA kits, Nhlrc2 Proteins

Many biological assays use antibodies to detect Nhlrc2, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with Nhlrc2 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop Nhlrc2 antibodies...

We validate the specificity of these antibodies to Nhlrc2 by testing them on tissues known to express Nhlrc2 positively and negatively. Browse below to find the Nhlrc2 antibody that suites your experiment. We have 3 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: Hmg20a

Nhlrc2 Infographic by Boster Bio

All Nhlrc2 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

NHLRC2 (NM_198514) Human Recombinant Protein

$813
Cat # PROTQ8NBF2
20 µg

NHLRC2 (NM_198514) Human Over-expression Lysate

Human

$960
Cat # LS374354
100 µg

Anti-NHLRC2 Antibody Picoband®

Human

ELISA, Flow Cytometry, WB

$370
Cat # A17232-1
100 µg/vial

Nhlrc2 Overview

Facts about NHL repeat-containing protein 2.

NHL repeat-containing protein 2 (Nhlrc2)

Gene Information

Mouse
Gene Name:	Nhlrc2
Uniprot:	Q8BZW8
Entrez:	66866

Family

Belongs to:

No superfamily

Alternative Names

DKFZp779F115,1200003G01Rik; FLJ20147; FLJ25621; FLJ33312; MGC45492; NHL repeat containing 2; NHL Repeat-Containing Protein 2; NHLRC2; novel NHL repeat domain containing protein

Molecular Weight

Mass (kDA):
78.43 kDA

Genomic Context


Mouse

Location:	19\|19 D2
Sequence:	19;

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/Nhlrc2

References

PMID: 29423877 by Uusimaa J., et al. NHLRC2 variants identified in patients with fibrosis, neurodegeneration, and cerebral angiomatosis (FINCA): characterisation of a novel cerebropulmonary disease.